Pro Medicus Limited
PME
Rang in Aktien
#1594
Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a... Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a leading provider of medical imaging software and services. The company develops and delivers advanced solutions to hospitals, diagnostic imaging groups, and other healthcare organizations across Australia, North America, and Europe. Their core offerings include proprietary Radiology Information Systems (RIS), which streamline practice management and come with comprehensive support, training, installation, and professional services. Pro Medicus also operates Promedicus.net, an e-health platform, and supplies sophisticated imaging software designed to provide radiologists and clinicians with powerful visualization capabilities for 2D, 3D, and 4D medical images. This suite of tools is further enhanced by Picture Archiving and Communication System (PACS)/digital imaging software and integration products. Additionally, they offer mobile applications like Visage Ease Pro, which enables remote interpretation of diagnostic imaging studies stored on a Visage 7 server. Key product brands include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease.
Aktienkurs
$130.13
Marktkapitalisierung
$13.59B
Veränderung (1 Tag)
0.46%
Veränderung (1 Jahr)
-30.39%
Land
AU
Handel Pro Medicus Limited (PME)
Kategorie
Healthcare
Anzahl der ausstehenden Aktien von Pro Medicus Limited (PME)
Anzahl der ausstehenden Aktien zum June 2026: 104.47M
Laut den neuesten Finanzberichten und dem Aktienkurs von Pro Medicus Limited beträgt die aktuelle Anzahl der ausstehenden Aktien 104.47M. Am Ende von June 2024 hatte das Unternehmen 104.44M ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von Pro Medicus Limited (PME) von 2000 bis 2026
Ausstehende Aktien am Ende jedes Jahres
| Jahr | Ausstehende Aktien | ändert |
|---|---|---|
| 2026 (TTM) | 104.47M | -0.01% |
| 2025 | 104.48M | 0.03% |
| 2024 | 104.44M | 0.03% |
| 2023 | 104.41M | 0.09% |
| 2022 | 104.31M | 0.14% |
| 2021 | 104.17M | 0.26% |
| 2020 | 103.90M | 0.31% |
| 2019 | 103.57M | 0.37% |
| 2018 | 103.19M | 0.69% |
| 2017 | 102.49M | 1.09% |
| 2016 | 101.38M | 1.11% |
| 2015 | 100.26M | 0.00% |
| 2014 | 100.26M | 0.92% |
| 2013 | 99.35M | -0.91% |
| 2012 | 100.26M | -0.02% |
| 2011 | 100.28M | 0.00% |
| 2010 | 100.28M | 0.00% |
| 2009 | 100.28M | 0.00% |
| 2008 | 100.28M | 0.26% |
| 2007 | 100.02M | 0.02% |
| 2006 | 100.00M | 0.00% |
| 2005 | 100.00M | 0.00% |
| 2004 | 100.00M | 0.00% |
| 2003 | 100.00M | 0.00% |
| 2002 | 100.00M | 0.00% |
| 2001 | 100.00M | 0.00% |
| 2000 | 100.00M | 0.00% |
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
| Unternehmen | Ausstehende Aktien | Unterschied | Land |
|---|---|---|---|
| 453.00M | 333.62% |
US
|
|
| 205.38M | 96.59% |
US
|
|
| 179.92M | 72.22% |
US
|
|
| 129.98M | 24.42% |
US
|
|
| - | - |
US
|
